Skip to main content
. Author manuscript; available in PMC: 2016 Aug 11.
Published in final edited form as: Arch Pharm (Weinheim). 2013 Jan;346(1):23–33. doi: 10.1002/ardp.201200334

Table 1.

PDE5 inhibitory activity of 1, 3-disubstituted tetrahydro-β-carbolines (14) and the fully aromatic β-carboline 25.

Compound Chirality PDE5 % inhibition at 10 μma) PDE5 inhibition IC50 (μm)
1 1S, 3R <60 ND
2 1R, 3R <60 ND
3 1R, 3S <60 ND
4 1S, 3S <60 ND
25 NA <60 ND
a)

Calculated from triplicate values.